Literature DB >> 16917117

Angiopoietin/Tie2 pathway influences smooth muscle hyperplasia in idiopathic pulmonary hypertension.

Laurence Dewachter1, Serge Adnot, Elie Fadel, Marc Humbert, Bernard Maitre, Anne-Marie Barlier-Mur, Gerald Simonneau, Michel Hamon, Robert Naeije, Saadia Eddahibi.   

Abstract

RATIONALE: Angiopoietins are involved in blood vessel maturation and remodeling.
OBJECTIVES: One consequence of endothelium-specific tyrosine kinase-2 (Tie2) receptor activation by angiopoietin-1 (Ang1) is the release of endothelium-derived growth factors that recruit vascular wall cells. We investigated this process in idiopathic pulmonary arterial hypertension (iPAH).
METHODS: Ang1, Ang2, and total and phosphorylated Tie2 expression (mRNA and protein) was evaluated in human lung specimens and in cultured pulmonary artery smooth muscle cells (PA-SMCs) and pulmonary endothelial cells (P-ECs) isolated from patients with iPAH and control subjects. Media collected from Ang1-treated P-ECs were assessed for their PA-SMC growth-promoting effect.
MEASUREMENTS AND MAIN RESULTS: Tie2 receptor was fourfold higher in lungs and P-ECs from patients with iPAH than in those from control subjects, with a parallel increase in phosphorylated lung Tie2 receptor. In contrast, Ang1 and Ang2 expression in lungs, P-ECs, and PA-SMCs did not differ. Incubation of PA-SMCs with medium collected from P-EC cultures induced marked proliferation, and this effect was stronger when using P-ECs from patients with iPAH than from control subjects. Ang1 pretreatment of P-ECs from either patients or control subjects induced a further increase in PA-SMC proliferation. Fluoxetine, an inhibitor of the mitogenic action of serotonin, reduced the growth-promoting effect of P-EC media. Ang1 added to P-ECs from patients with iPAH increased the production of endothelin-1 (ET-1) and serotonin, but not of platelet-derived growth factor-BB or epidermal growth factor, and increased the amount of mRNA encoding tryptophan hydroxylase-1 (the rate-limiting enzyme of serotonin synthesis), preproET-1, and ET-1-converting enzyme.
CONCLUSIONS: The Ang1/Tie2 pathway is potentiated in iPAH, contributing to PA-SMC hyperplasia via increased stimulation of endothelium-derived growth factors synthesis by P-ECs.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16917117     DOI: 10.1164/rccm.200602-304OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  39 in total

1.  Paracrine modulation of cholangiocyte serotonin synthesis orchestrates biliary remodeling in adults.

Authors:  Alessia Omenetti; Liu Yang; Raul R Gainetdinov; Cynthia D Guy; Steve S Choi; Wei Chen; Marc G Caron; Anna Mae Diehl
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-11-11       Impact factor: 4.052

2.  Autocrine fibroblast growth factor-2 signaling contributes to altered endothelial phenotype in pulmonary hypertension.

Authors:  Ly Tu; Laurence Dewachter; Benoit Gore; Elie Fadel; Philippe Dartevelle; Gérald Simonneau; Marc Humbert; Saadia Eddahibi; Christophe Guignabert
Journal:  Am J Respir Cell Mol Biol       Date:  2010-10-29       Impact factor: 6.914

3.  Downregulated bone morphogenetic protein signaling in nitrofen-induced congenital diaphragmatic hernia.

Authors:  Martine Makanga; Céline Dewachter; Hidekazu Maruyama; Aline Vuckovic; Benoit Rondelet; Robert Naeije; Laurence Dewachter
Journal:  Pediatr Surg Int       Date:  2013-07-06       Impact factor: 1.827

Review 4.  Molecular pathogenesis of pulmonary arterial hypertension.

Authors:  Marlene Rabinovitch
Journal:  J Clin Invest       Date:  2008-07       Impact factor: 14.808

5.  Defective angiogenesis in hypoplastic human fetal lungs correlates with nitric oxide synthase deficiency that occurs despite enhanced angiopoietin-2 and VEGF.

Authors:  Olivier Boucherat; Marie-Laure Franco-Montoya; Christophe Delacourt; Jelena Martinovic; Virginie Masse; Caroline Elie; Bernard Thébaud; Alexandra Benachi; Jacques R Bourbon
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2010-03-26       Impact factor: 5.464

6.  Restoration of impaired endothelial myocyte enhancer factor 2 function rescues pulmonary arterial hypertension.

Authors:  Jongmin Kim; Cheol Hwangbo; Xiaoyue Hu; Yujung Kang; Irinna Papangeli; Devi Mehrotra; Hyekyung Park; Hyekyung Ju; Danielle L McLean; Suzy A Comhair; Serpil C Erzurum; Hyung J Chun
Journal:  Circulation       Date:  2014-10-21       Impact factor: 29.690

Review 7.  Molecular pathogenesis of pulmonary arterial hypertension.

Authors:  Marlene Rabinovitch
Journal:  J Clin Invest       Date:  2012-12-03       Impact factor: 14.808

Review 8.  Pathogenic mechanisms of pulmonary arterial hypertension.

Authors:  Stephen Y Chan; Joseph Loscalzo
Journal:  J Mol Cell Cardiol       Date:  2007-09-20       Impact factor: 5.000

9.  Temporal changes of angiopoietins and Tie2 expression in rat lungs after monocrotaline-induced pulmonary hypertension.

Authors:  Yu Ji Cho; Jae Yoon Han; Sang Gab Lee; Byeong Tak Jeon; Wan Sung Choi; Young Sil Hwang; Gu Seob Roh; Jong Deog Lee
Journal:  Comp Med       Date:  2009-08       Impact factor: 0.982

10.  The angiopietin-1-Tie2 pathway prevents rather than promotes pulmonary arterial hypertension in transgenic mice.

Authors:  Lakshmi Kugathasan; Julie Basu Ray; Yupu Deng; Effat Rezaei; Daniel J Dumont; Duncan J Stewart
Journal:  J Exp Med       Date:  2009-09-08       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.